BCYC Q4 2023 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+67.4% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$54M-1017.4% margin

Net Income

-$49M-921.0% margin

EPS (Diluted)

$-1.16

QoQ Revenue Growth

-0.4%

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$47M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$595M

Total Liabilities

$224M

Stockholders' Equity

$371M

Cash & Equivalents

$526M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$3M	+67.4%
Gross Profit	$5M	$3M	+67.4%
Operating Income	-$54M	-$32M	-68.4%
Net Income	-$49M	-$30M	-63.8%